Your session is about to expire
← Back to Search
Chemo-Radiation for Early-Stage Cervical Cancer
Study Summary
This trial is studying how well giving chemotherapy and pelvic radiation therapy together with or without additional chemotherapy works in treating patients with high-risk early-stage cervical cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2010 Phase 2 trial • 13 Patients • NCT02006667Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have a severe lung condition that would stop me from joining the study.My cancer does not have neuroendocrine features.My cancer has not spread to distant parts of my body.I can carry out all my usual activities without help.I am HIV positive with a CD4 count of at least 350.I have had previous radiation treatment to my pelvis.I had a major surgery for my cancer that included removing my uterus and checking if the cancer has spread, within the last 70 days.My PET scans show no cancer in the para-aortic nodes.My cancer does not have large, visible tumors after surgery.I haven't had any other cancer besides the specified one in the last 3 years.I have not been hospitalized for heart issues in the last 6 months.I had a major heart attack in the last 6 months.I am receiving IV antibiotics for a bacterial or fungal infection.I have had chemotherapy for my current cervical cancer.My cervical cancer surgery showed high-risk features but no spread to para-aortic nodes.My cancer is in an early stage (IA2, IB, IIA).I have had lymph node sampling in my pelvis and near my aorta.I have a blood clotting disorder.I do not have any severe ongoing health issues.
- Group 1: Arm I: Cisplatin/Radiation Therapy
- Group 2: Arm II: Cisplatin/Radiation Therapy + Carboplatin/Paclitaxel
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What cancers does cisplatin commonly target?
"cisplatin is most commonly used as treatment for advanced endometrial cancer. It can also be taken to treat other conditions like melanoma, neoplasm metastasis, lymphoma, and non-hodgkin."
Can you please share other research that has been conducted with cisplatin?
"City of Hope Comprehensive Cancer Center first studied cisplatin in 1997 and there have been 2265 completed trials to date. There are 1592 clinical trials still underway, with a large contingent being based in Sacramento, Pennsylvania."
Is this clinical trial available in multiple states?
"There are 6 sites enrolling patients for this trial, 3 of which are located in Wynnewood, Sacramento and Sioux Falls. The other 3 sites are in close proximity to these locations. If you enroll, it would be beneficial to choose the location closest to you in order to reduce travel."
Has cisplatin been federally recognized in the United States?
"There is some clinical data supporting cisplatin's efficacy and it has undergone multiple rounds of testing for safety, so it received a score of 3."
How many individuals are receiving care through this experiment?
"As of right now, this clinical trial is not open to new patients. It was originally posted on September 1st, 2009 and was most recently edited on April 4th, 2022. However, there are presently 408 trials actively recruiting patients with cervical cancer and 1592 studies using cisplatin that are still admitting patients."
Are there still available positions for participants in this clinical trial?
"Unfortunately, this particular clinical trial is not presently looking for participants. Although, this may be subject to change as the study was most recently updated on 4/4/2022. There are 2000 other studies that are actively recruiting patients."
Share this study with friends
Copy Link
Messenger